Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
Phosphoproteomics platform for kinase activity profiling and precision oncology
Kinomica is a UK precision medicine company developing phosphoproteomics technology for drug discovery and companion diagnostics. Its platform combines LC-MS/MS mass spectrometry…
LNP-mRNA growth factor therapy to restore hearing loss
CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause. Its lead…
Preclinical DMPK, bioanalysis and toxicology CRO
Pharmidex is a UK contract research organisation providing preclinical drug discovery and development services across DMPK, bioanalysis, toxicology, histology and in vitro ADME.…
AI-driven target discovery from human tissue omics
Relation is a platform biotechnology company integrating machine learning with single-cell and spatial multi-omics data derived directly from patient tissue to discover and…
UK's largest early-phase clinical CRO specialising in first-in-human trials
Hammersmith Medicines Research is one of the largest early-phase contract research organisations in Europe, specialising in Phase I and early Phase II clinical trials of…
European hub for RNAi therapeutics developer
Alnylam UK is the European operational headquarters of Alnylam Pharmaceuticals, the pioneer of RNA interference therapeutics. Based in Maidenhead, the UK office serves as…
Bespoke bio-analysis and biomarker CRO services for drug discovery
Tetrad Discovery is a preclinical contract research organisation providing bespoke bio-analysis services to pharmaceutical and biotechnology sponsors. The company offers tailored…
3D-bioprinted patient-derived tumour models for oncology drug screening
Carcinotech is a contract research and tumour model manufacturing company that produces 3D-bioprinted micro-tumours for preclinical oncology drug screening and personalised…
AI platform integrating biology, chemistry and automation for drug discovery
Recursion is a clinical-stage biotechnology company using AI and robotic wet-lab automation to industrialise small molecule drug discovery. Its platform integrates phenomics,…
AI-driven combinatorial analytics platform for chronic disease biology
PrecisionLife is a computational biology company applying AI-driven combinatorial analytics to complex chronic diseases. Its platform identifies causal biological mechanisms and…
Culturing microbial dark matter to discover novel antimicrobials and bioactives
Bactobio is a biotechnology company using synthetic biology, next-generation sequencing, and machine learning to culture the vast majority of environmental microbes that have…
Native mass spectrometry platform for small molecule drug discovery
OMass Therapeutics is a biotechnology company developing small molecule therapeutics against membrane proteins, GPCRs, and intracellular complexes that have historically been…